Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $150 billion and annual revenue exceeding $59 billion, announced today that its Phase 3 BREAKWATER study ...

Euphoria in Silicon Valley turned to panic this week after a Chinese-based startup called DeepSeek released a new large language model (LLM). It’s very good. And it’s very cheap. Not only did DeepSeek ...